CD44 and head and neck squamous cell carcinoma: First, we showed that c-Met expression positively correlated with that of STAT3 and CD44 in HNSCC clinical databases, and high c-Met expression predicted significantly lower overall and disease-free survival rates in HNSCC clinical cohorts.